Less than 1 min.Read

Luca Science: Raises $M in Series A Financing

September 2, 2020

The round was led by Axil Capital Partners, with participation from Remiges Ventures, Nippon Venture Capital, Fast Track Initiative and CaHC
Luca Science is a preclinical biopharmaceutical company focusing on the discovery of novel mitochondria therapy to treat diseases and injuries in multiple therapeutic areas
Mitochondria are the power plants in human cells that produce energy for human bodies
These small intracellular organelles house cellular aerobic respiration, the process also used to turn oxygen and nutrients into energy
Then the company is developing an innovative platform of highly functional mitochondrial using proprietary technologies
Its mitochondria can stored and delivered as a biopharmaceutical agent